Cencora participated in RAPS Convergence, the world's largest annual gathering of regulatory professionals and innovators, where multiple stakeholders shared and discussed regulatory insights and business strategy. Michael Day, Senior Director of Regulatory Strategy and CMC at Cencora, presented best practices on identifying and mitigating risks behind recent FDA Complete Response Letters (CRLs). The event provided valuable opportunities to network and explore key industry issues.
Article
RAPS Convergence 2025: Transparency, Trust, and Resilience in Regulatory Science
RAPS Convergence 2025 highlighted an important transition across the regulatory landscape. Regulators and sponsors are expected to operate with greater visibility—communicating decisions, sharing data, and adapting plans in real time. Across plenary and technical sessions, the focus was on how to maintain scientific integrity and consistency while managing growing public scrutiny and complex product development. Read the article to learn more.
With team across North America, Europe, and Asia-Pacific region, we blend global reach with local expertise
3,000
Consultants worldwide
30+
Global markets covered
235+
Brands represented
Navigate the regulatory approval process with ease
Whether you are developing medicinal products, consumer healthcare products, or veterinary products, our team has the necessary scientific, regulatory, and technical experience to support you. Our regulatory affairs, operations, and chemistry, manufacturing, and controls (CMC) services portfolio supports companies of all sizes across the product life cycle, from product development and initial submission through launch and life cycle management.
Webinar
Know Your Market: US and EU Regulatory Expectations for Combination Products
The increased prevalence of combination products requires a deeper understanding of what regulators expect in different markets and the kinds of studies required. Manufacturers will need to consider how to manage the different regulatory activities, such as usability testing and bridging studies, that are involved with drug and device development.
Connect with our team
Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.
